-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RnQmVVeMVBHVDel8RbM9tPCeweMfK2C0PWClzpayGNVZntDKRuTddcoY0NRVBTr8 ChYucyfvUxquCOMmc3fu4A== 0000903423-05-000794.txt : 20051006 0000903423-05-000794.hdr.sgml : 20051006 20051006172405 ACCESSION NUMBER: 0000903423-05-000794 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20051004 FILED AS OF DATE: 20051006 DATE AS OF CHANGE: 20051006 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cohen Fred E CENTRAL INDEX KEY: 0001339358 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 051127844 BUSINESS ADDRESS: BUSINESS PHONE: 1 415 743 1661 MAIL ADDRESS: STREET 1: 345 CALIFORNIA STREET SUITE 2600 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 4 1 cohen-f4_1005ex.xml X0202 4 2005-10-04 0 0001131324 GENOMIC HEALTH INC GHDX 0001339358 Cohen Fred E C/O TPG VENTURES 345 CALIFORNIA STREET SUITE 2600 SAN FRANCISCO CA 94104 1 0 0 0 Common Stock par value $1.00 2005-10-04 4 C 0 33333 A 43351 D Series A Preferred Stock 2005-10-04 4 C 0 99999 D Common Stock 33333 0 D On September 8, 2005, the Issuer declared a conditional dividend of 791,210 shares of Common Stock to be distributed on a pro rata basis to the Issuer's stockholders of record at the commencement of the Issuer's initial public offering ("IPO") if the price per share of Common Stock sold in the IPO is $11.40 or greater. As a result, the Reporting Person received 1,685 shares of Common Stock as of October 4, 2005, the closing date of the IPO, which is reflected in the amount of Common Stock reported in column 5. Every three shares of Preferred Stock were converted into one share of Common Stock upon consummation of the IPO. This conversion rate is reflected in the amount of securities underlying the derivative security reported in column 7, which also reflects adjustment for the stock split by the Issuer on September 8, 2005. These securities are exercisable immediately. These securities to do not have an expiration date. Does not include 1,014,492 shares of Series D Preferred Stock and 821,513 shares of Series E Preferred Stock previously held by funds managed by Tarrant Advisors, Inc., with which Mr. Cohen is affiliated. These shares of Preferred Stock were also converted on October 4, 2005 as reported in a seperate Form 4 filed by Tarrant Advisors, Inc. /s/ Fred E. Cohen 2005-10-04 -----END PRIVACY-ENHANCED MESSAGE-----